Literature DB >> 3872755

Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

J Alcocer-Varela, E Martinez-Cordero, D Alarcon-Segovia.   

Abstract

Interleukin-1 (IL-1) is a monocyte derived factor that participates in immune regulation and in the regulation of fibroblast proliferation and collagen deposition. It therefore, seems particularly pertinent to study in scleroderma, a disorder of immune regulation where increased collagen deposition is a hallmark. The production of IL-1 by lipopolysaccharide stimulated monocytes from 18 untreated scleroderma patients was akin to that of their normal matched controls. However, the unstimulated monocytes from six of the 18 scleroderma patients released IL-1 activity spontaneously into their supernatants. All six patients with spontaneous IL-1 release had less than 5 years disease duration. The response to IL-1 by T lymphocytes from patients with scleroderma was low as compared to those from controls. The presence of spontaneous IL-1 production with decreased response to IL-1 in scleroderma may indicate an in vivo pre-activation of monocytes to produce this factor that might have a bearing in the pathogenesis of collagen deposition in scleroderma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872755      PMCID: PMC1576921     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production.

Authors:  S M Wahl; L M Wahl; J B McCarthy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

3.  Studies on the role of lymphocyte-activating factor (Interleukin 1) in antigen-induced lymph node lymphocyte proliferation.

Authors:  S B Mizel; A Ben-Zvi
Journal:  Cell Immunol       Date:  1980-09-01       Impact factor: 4.868

4.  Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function.

Authors:  R S Krakauer; J Sundeen; D N Sauder; A Scherbel
Journal:  Arch Dermatol       Date:  1981-02

5.  Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.

Authors:  S Gupta; A N Malaviya; P Rajagopalan; R A Good
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Monokine-induced synthesis of serum amyloid A protein by hepatocytes.

Authors:  M J Selinger; K P McAdam; M M Kaplan; J D Sipe; S N Vogel; D L Rosenstreich
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

7.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.

Authors:  D Alarcón-Segovia; R Palacios; G Ibáñez de Kasep
Journal:  J Clin Lab Immunol       Date:  1981-05

9.  Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice.

Authors:  J D Sipe; S N Vogel; J L Ryan; K P McAdam; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

10.  The functional relationship of the interleukins.

Authors:  K A Smith; L B Lachman; J J Oppenheim; M F Favata
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  13 in total

1.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin.

Authors:  J A Elias; R C Krol; B Freundlich; P M Sampson
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

5.  Release of interleukin-1 by peripheral blood mononuclear cells in patients with tuberculosis and active inflammation.

Authors:  S W Chensue; M P Davey; D G Remick; S L Kunkel
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

6.  Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica.

Authors:  J Sanchez-Roman; I Wichmann; J Salaberri; J M Varela; A Nuñez-Roldan
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

7.  Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  Sera from patients with systemic lupus erythematosus demonstrate enhanced IgG binding to endothelial cells pretreated with tumour necrosis factor alpha.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

Authors:  J Rosenbaum; B E Pottinger; P Woo; C M Black; S Loizou; M A Byron; J D Pearson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.

Authors:  F E Clay; M J Cork; J K Tarlow; A I Blakemore; C I Harrington; F Lewis; G W Duff
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.